As the pandemic continues to evolve, Roche’s mission to serve patients remains unchanged. We understand the importance of timely availability and fast access to reliable, high-quality tests, which are essential for healthcare systems and patients alike.
Ensuring broad access to diagnostic testing has been a priority for us since the start of the pandemic.
We are proud to support the U.S. government’s efforts to expand access to testing, and that the Roche COVID-19 At-Home Test, a rapid antigen testing solution, will be made available for free to American families.
As the public continues to manage day-to-day living during the pandemic, the need has increased significantly for more reliable at-home rapid tests that detect the delta and now omicron variants of COVID-19. The Roche COVID-19 At-Home Test offers a convenient, frequent testing option that delivers quick, accurate results and provides peace of mind. It’s an important tool in the fight against COVID-19.
We are committed to partnering with organizations that are working to deliver tests to those who need them most, and we’re hopeful that long-term barriers to diagnostic testing can be reduced.
As long as a need for reliable testing remains, Roche will continue to invest in effective solutions to make testing options available when and where people need them.
To address the global COVID-19 healthcare crisis, Roche has launched a growing number of diagnostic solutions that help detect and diagnose the infection in patients, as well as providing digital support to healthcare systems. Roche has one of the broadest portfolios for COVID-19 testing, with eight EUAs in the U.S. since the start of the pandemic, including the first PCR test in March 2020.
Right click and Save Image As to download image